Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
America Great HealthAAGH -20.00% EV-to-EBITDA is 7.12 as of Sep. 09, 2026. The stock has 4 warning signs investors should review. Among 400 Biotechnology companies, America Great Health ranks better than 63.5% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, America Great Health's enterprise value is $7.24 Mil.
America Great Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $1.02 Mil. Therefore, America Great Health's EV-to-EBITDA for today is 7.12.
The historical rank and industry rank for America Great Health's EV-to-EBITDA or its related term are showing as below:
AAGH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 8.16
Current: 7.12
During the past 13 years, the highest EV-to-EBITDA of America Great Health was 8.16. The lowest was 0.00. And the median was 0.00.
AAGH's EV-to-EBITDA is ranked better than 63.5% of 400
companies
in the Biotechnology industry
Industry Median: 13.615
vs AAGH: 7.12
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
America Great Health (OTCPK:AAGH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
America Great Health's PE Ratio (TTM) for today is calculated as:
America Great Health's share price for today is $0.0002.
America Great Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for America Great Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, America Great Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
America Great Health EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, America Great Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where America Great Health's EV-to-EBITDA falls into.
America Great Health's current Enterprise Value is $7.24 Mil.
America Great Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
America Great Health (AAGH) has a EV-to-EBITDA of 7.12 as of Sep. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on America Great Health. According to the industry distribution chart, America Great Health ranks #146 out of 400 companies in the Biotechnology industry, placing it in the top 36.5%.
Is America Great Health's EV-to-EBITDA too high?
America Great Health's current EV-to-EBITDA is 7.12. The Biotechnology industry median EV-to-EBITDA is 13.62. America Great Health's value of 7.12 is 47.7% below this industry median. Based on the distribution chart, America Great Health ranks #146 out of 400 companies in the Biotechnology industry, which is above the industry midpoint.
How does America Great Health's EV-to-EBITDA compare to HCWB and CLGN?
According to the Biotechnology industry distribution chart, America Great Health ranks #146 out of 400 companies for EV-to-EBITDA. This puts America Great Health in the upper half of its industry. The industry median EV-to-EBITDA is 13.62. America Great Health's value of 7.12 is 47.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.62, based on 400 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. America Great Health's current EV-to-EBITDA of 7.12 is 47.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on America Great Health. For the Biotechnology industry, the median EV-to-EBITDA is 13.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. America Great Health's current EV-to-EBITDA is 7.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is America Great Health stock overvalued right now?
America Great Health (AAGH) has a current EV-to-EBITDA of 7.12. The current EV-to-EBITDA is 7.12 and 47.7% below the Biotechnology industry median of 13.62. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For America Great Health (AAGH), the current EV-to-EBITDA is 7.12 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AAGH has been successfully added to your 
